EAHAD 2024: Interim Results of the First-in-Human Investigation of HMB-001 for Prophylactic Management of Glanzmann Thrombasthenia
Presented at 17th Annual Congress of the European Association of Haemophilia and Allied Disorders
To view the presentation, click here